Abstract 2939: Discovery and synthesis of highly potent and selective small molecule inhibitors of the histone methyltransferase EZH2
Sharad K. Verma(GlaxoSmithKline (United States)), Dash Dhanak(Springhouse), Dominic Suarez(GlaxoSmithKline (United States)), Alan P. Graves(GlaxoSmithKline (United States)), Mark Mellinger(GlaxoSmithKline (United Kingdom)), Michael T. McCabe(GlaxoSmithKline (United States)), Art Shu(GlaxoSmithKline (United States)), Louis V. LaFrance(Johnson & Johnson (United States)), Steven D. Knight(GlaxoSmithKline (United States)), Xinrong Tian(GlaxoSmithKline (United Kingdom)), James Brackley(GlaxoSmithKline (United States)), Stuart P. Romeril(GlaxoSmithKline (United States)), Céline Duquenne(GlaxoSmithKline (United Kingdom)), Peter J. Tummino(Intarcia Therapeutics (United States)), Elsie Diaz(Johnson & Johnson (United States)), Heidi Morgan-Ott(GlaxoSmithKline (United States)), D. Scherzer(GlaxoSmithKline (United States)), Ryan G. Kruger(Arysta LifeScience (France)), Neil W. Johnson(Brandywine Photonics (United States)), Joelle L. Burgess(GlaxoSmithKline (United States)), Caretha L. Creasy, Seth W. Grant(GlaxoSmithKline (United States)), William H. Miller(Clinical Innovations (United States)), K. A. NEWLANDER(South College), BaoChau Le(GlaxoSmithKline (United States)), Christine Thompson(GlaxoSmithKline (United Kingdom)), Charles F. McHugh(GlaxoSmithKline (United States))
Cited by 1
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848